Punia Vikram Singh

Biography

When Vikram Singh Punia entered pharma business in Russia in 1997, there were sceptical sniggers. He now heads a thriving company, with ambitious growth plans. Pharmaceutical industry topped the list of subject discussed during the recent 5th Indo-Russian trade and investment forum in Moscow. “And it's not surprising,” says Vikram Punia, the head of pharmaceutical company Pharmasynthez. “I think this event helps us not only to find business partners, but also produces concrete results. Previously, it helped us to launch the production of medications for treating oncological diseases,” says Mr.Punia, an Indian businessman who is making a mark in Russia’s business landscape. The Indian pharmaceutical industry has seen rapid advancement of new technologies, stressed Mr. Vikram, who has worked in the pharma business for 15 years. Educated in the Irkutsk Medical Institute, Punia believes that sharing the experience of Indian chemists and technologists can be useful for the Russian market. He points that the price of generic medicines made by Russian producers are several times higher than the Indian ones. But while keeping pace with the fast progress of new technologies, he says, it’s essential to make the best usage of the drugs already in production. “Although innovations are important, we shouldn’t forget that 90% of diseases can be cured using existing medications,” he points out.

Research Interest

Drug Productions, Manufacturing technologies